IOBT Q2 2021 Earnings — IO Biotech, Inc. Revenue & Financial Results | Market Cap Arena

IOBTIO Biotech, Inc.

$18M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$9M

Net Income

-$38M

EPS (Diluted)

$-3.32

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$5,000

Balance Sheet

Total Assets

$59M

Total Liabilities

$8M

Stockholders' Equity

$51M

Cash & Equivalents

$55M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$9M	-$2M	-330.3%
Net Income	-$38M	-$3M	-1178.6%